Accuray Incorporated (ARAY) analyst actions
Rating and price-target actions on ARAY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ARAY overview →
2 measured ARAY analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training | Press release | -0.56% | +1.12% | |
| Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System | Press release | +0.77% | +5.36% |
Keep exploring
More ARAY: earnings → · SEC filings → · ARAY overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CRISPR Therapeutics AG - Common Shares (CRSP) | 291 | +0.10% | 53% |
| Seres Therapeutics, Inc. (MCRB) | 290 | -0.23% | 46% |
| Chemed Corp (CHE) | 288 | +0.02% | 53% |
| Fate Therapeutics, Inc. (FATE) | 287 | -0.76% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.